ATAI LIFE SCIENCES N.V.

(ATAI)
  Rapporto
Tempo differito Nasdaq  -  23/05 22:00:00
3.870 USD   -3.25%
17/05ATAI LIFE SCIENCES N.V.: Citigroup è per il Buy
MM
16/05AGGIORNAMENTO SETTORIALE: i titoli del settore sanitario salgono prima della campanella di lunedì
MT
16/05Atai Life Sciences ha registrato una perdita nel primo trimestre.
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ATAI LIFE SCIENCES N.V.
16/05SECTOR UPDATE: Health Care Stocks Edge Higher Pre-Bell Monday
16/05ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
16/05TRANSCRIPT: Atai Life Sciences N.V., Q1 2022 Earnings Call, May 16, 2022
16/05Atai Life Sciences Swings to Loss in Q1
16/05atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 und Unternehmens-Up..
16/05atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 und Unternehmens-Up..
16/05atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update
16/05Atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update
16/05Atai Life Sciences N.V. Reports Earnings Results for the First Quarter Ended March 31, ..
13/05IntelGenx Technologies Reports First Quarter 2022 Financial Results
06/05KORREKTUR - atai Life Sciences gibt Finanzergebnisse für das erste Quartal 2022 und Unt..
06/05KORREKTUR - atai Life Sciences gibt Finanzergebnisse für das erste Quartal 2022 und Unt..
05/05CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Bu..
05/05CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Bu..
04/05atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 vor
04/05atai Life Sciences to Announce First-Quarter 2022 Financial Results
04/05Atai Life Sciences to Announce First-Quarter 2022 Financial Results
20/04atai Life Sciences ist Teilnehmer der im April stattfindenden Investorenkonferenz
20/04atai Life Sciences ist Teilnehmer der im April stattfindenden Investorenkonferenz
19/04atai Life Sciences to Participate in Upcoming April Investor Conference
18/04European ADRs Nudge Higher in Monday Trading
14/04European ADRs Move Lower in Thursday Trading
13/04European ADRs Move Higher in Wednesday Trading
30/03ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
30/03TRANSCRIPT: Atai Life Sciences N.V., Q4 2021 Earnings Call, Mar 30, 2022
30/03ATAI LIFE SCIENCES N: Announces Fourth Quarter and Full Year 2021 Financial Results, Repo..
30/03ATAI Life Sciences' Q4 Loss Widens
30/03Atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Repor..
30/03Atai Life Sciences N.V. Reports Earnings Results for the Full Year Ended December 31, 2..
23/03Atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourt..
22/03TRANSCRIPT: Atai Life Sciences N.V. Presents at Citi’s 2022 Winter Biotech Virtual B..
21/03atai Life Sciences to Participate in Upcoming March Investor Conferences
21/03atai Life Sciences to Participate in Upcoming March Investor Conferences
16/02atai Impact spendet an die Multidisciplinary Association for Psychedelic Studies (MAPS)..
16/02Atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)..
15/02Atai Life Sciences to Participate in Upcoming February Investor Conference
27/01Atai Launches Platform Company Invyxis, Partners With Dalriada to Develop Mental Health..
27/01Dalriada Drug Discovery Announces Strategic Collaboration with Atai Life Sciences' N.V
27/01Atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental H..
27/01atai Life Sciences N.V. Launches Invyxis to Accelerate Discovery of Next-Generation Men..
18/01TRANSCRIPT: Atai Life Sciences N.V. - Special Call
12/01ATAI LIFE SCIENCES: FDA Grants Investigational New Drug to PCN-101 R-ketamine Program
12/01Atai Life Sciences Receives FDA Clearance to Conduct Anti-Depressant Study
12/01Atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R..
12/01Atai Life Sciences Announces Fda Investigational New Drug Clearance for Pcn-101 R-Ketam..
2021European ADRs Move Lower in Monday Trading
2021ATAI LIFE SCIENCES N.V.(NASDAQGM: ATAI) added to S&P Global BMI Index
2021ATAI LIFE SCIENCES N.V.(NASDAQGM: ATAI) added to NASDAQ Biotechnology Index
2021European ADRs Move Higher in Thursday Trading
2021Atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massa..
2021US Stocks Recover From Two-Day Slump as Fed Moves to Double Taper Pace
2021US Stocks Recover From Two-Day Slump as Fed Moves to Double Taper Pace
2021Health Care Stocks Continue Gaining into Wednesday Close
2021Top Midday Decliners
2021Atai Life Sciences Enters Into Extended Lock-Up Deals With Key Pre-IPO Investors; Stock..
2021Health Care Stocks Rising Wednesday Afternoon
2021European ADRs Move Slightly Lower in Wednesday Trading
2021ATAI LIFE SCIENCES N: Apeiron and Other Key Shareholders of atai Life Sciences Reinforce ..
2021ATAI LIFE SCIENCES N.V.: Regulation FD Disclosure, Financial Statements and Exhibits (for..
2021Certain Common Shares of Atai Life Sciences N.V. are subject to a Lock-Up Agreement End..
2021Certain Options of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on..
2021Atai Life Sciences Says Phase 2a Topline Data for RL-007 for Schizophrenia Supports Fur..
2021Atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 i..
2021atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 i..
2021European ADRs Move Lower in Monday Trading
2021Atai Life Sciences to be Added to Nasdaq Biotechnology Index
2021Atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
2021Atai Life Sciences Launches TryptageniX to Develop Potential Mental Health Treatments
2021Atai Life Sciences launches TryptageniX to further expand atai's robust intellectual pr..
2021Atai Life Sciences N.V. Announces the Launch of TryptageniX
2021European ADRs Nudge Higher in Wednesday Trading
2021Atai Life Sciences Boosts Stake in Compass Pathways
2021Atai Life Sciences Increases its Ownership Position in COMPASS Pathways
2021ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
2021European ADRs Move Slightly Higher in Monday Trading
1  2Pross.
Prossimo evento su ATAI LIFE SCIENCES N.V.